Key Market Indicators
Belgian Antiinfective Medicine Sales are projected to decline slightly over the next five years, reaching approximately $723 million by 2028 from about $732 million in 2023. This represents an average annual decrease of 0.2%. Historically, the Belgian market has been shrinking at a rate of 0.6% per year since 2007. In the 2023 rankings, Belgium held the sixth position, with Mexico surpassing it at $732 million. Spain, Croatia, and Australia occupied the second, third, and fourth spots, respectively. Belgian Antibiotics Exports are also on a downward trend, expected to fall to around $498 million by 2028 from nearly $539 million in 2023. This equates to an average annual decline of 1.4%. However, since 2004, the country's antibiotic supply has grown by 1.8% per year. On the import side, Belgian Antibiotics Imports are anticipated to decrease to roughly $448 million by 2028 from about $491 million in 2023, reflecting an average annual decline of 1.6%. Since 2004, the demand for antibiotics in Belgium has decreased by 0.6% annually.
